Organization Overview
Alternative names
allogeneic pancreatic islet cells (1 trial)
bevacizumab (avastin) (3 trials)
bicalutamide (casodex) (3 trials)
capecitabine (xeloda) (1 trial)
carboplatin (paraplatin) (1 trial)
cetuximab (erbitux) (2 trials)
cisplatin (platinol) (2 trials)
cyclophosphamide (cytoxan) (1 trial)
everolimus (zortress) (1 trial)
Filgrastim (neupogen) (1 trial)
fluorouracil (efudex) (6 trials)
gemcitabine (gemzar) (5 trials)
Adenocarcinoma (Phase 2)
Anus Neoplasms (Phase 2)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Asthma (Phase 4)
Burkitt Lymphoma (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Cholangiocarcinoma (Phase 2)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Colorectal Neoplasms (Phase 2)
Delirium (Phase 3)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 3)
Fallopian Tube Neoplasms (Phase 2)
Lower Urinary Tract Symptoms (Phase 4)
Lymphoma (Phase 2)
Ovarian Neoplasms (Phase 2)
Pain, Postoperative (Phase 3)
Pancreatic Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Polychondritis, Relapsing (Phase 1)
Prostatic Neoplasms (Phase 2)
Rectal Neoplasms (Phase 2)
Ulcer (Phase 2)